Daily Archives: 2012/04/03
Antibiotic May Pose Risk to Eyes (CME/CE)
(MedPage Today) -- The risk of retinal detachment was found to be higher among patients currently taking oral fluoroquinolones, although the absolute risk remained small, a case-control study showed.
Fluoroquinolones Linked to Retinal Detachments
A large retrospective study has shown that ophthalmology patients were 4.5 times more likely to have retinal detachment if they used fluoroquinolones.
Medscape Medical News
Medscape Medical News
Two phase III studies evaluate the use of combination verteporfin photodynamic therapy with ranibizumab for subfoveal choroidal neovascularisation secondary to AMD
Source: Ophthalmology
Area: News
According to the results of two phase III studies published in Ophthalmology, the addition of verteporfin photodynamic therapy (PDT) to ranibizumab injections is no better than ranibizumab alone for treating subfoveal choroidal neovascularisation secondary to age-related macular degeneration (AMD). The first study (MONT BLANC), compared the efficacy and safety of same-day verteporfin PDT and intravitreal ranibizumab combination treatment versus ranibizumab monotherapy in neovascular age-related macular degeneration. The prospective, double-blind, randomised, active-controlled trial involved 255 patients with all types of active subfoveal choroidal neovascularisation. Patients were randomised to combination treatment or ranibizumab alone (with placebo verteporfin), and received 3 consecutive monthly injections followed by as needed re-treatments based on protocol-specific re-treatment criteria. The primary outcome measure was the mean change in ...
Area: News
According to the results of two phase III studies published in Ophthalmology, the addition of verteporfin photodynamic therapy (PDT) to ranibizumab injections is no better than ranibizumab alone for treating subfoveal choroidal neovascularisation secondary to age-related macular degeneration (AMD). The first study (MONT BLANC), compared the efficacy and safety of same-day verteporfin PDT and intravitreal ranibizumab combination treatment versus ranibizumab monotherapy in neovascular age-related macular degeneration. The prospective, double-blind, randomised, active-controlled trial involved 255 patients with all types of active subfoveal choroidal neovascularisation. Patients were randomised to combination treatment or ranibizumab alone (with placebo verteporfin), and received 3 consecutive monthly injections followed by as needed re-treatments based on protocol-specific re-treatment criteria. The primary outcome measure was the mean change in ...
Bone Drugs May Raise Risk for Eye Pain (CME/CE)
(MedPage Today) -- Oral bisphosphonate therapy may boost the risk of inflammatory eye complications in first-time users versus nonusers, researchers found.
Avedro, ACOS commence accelerated corneal cross-linking Phase 3 study
ACOS and Avedro, Inc. jointly announced today the initiation of a Phase 3, multi-center, randomized, controlled evaluation to study accelerated corneal collagen cross-linking in eyes with keratoconus or corneal ectasia after refractive surgery.
UK surgeons told to stop using type of hip implant
LONDON (Reuters) - Britain's Medicines and Healthcare products Regulatory Agency has advised surgeons
to stop using a type of metal-on-metal hip implant because of the high risk of the need for revision surgery when
compared with other devices.
Feds raid ‘Princeton of Pot’ in California
OAKLAND, Calif. (Reuters) - U.S. federal agents, pressing a government clampdown on medical marijuana,
raided a San Francisco Bay-area college known as the "Princeton of Pot" on Monday and briefly
detained its founder.
Common antibiotics tied to eye emergencies: study
NEW YORK (Reuters Health) - Fluoroquinolone use was linked to a higher risk of retinal detachment in a
new Canadian study.
Subscribe
